Harmonic's current share price is a bargain per the price multiple model. Despite a positive profit outlook, growth isn't fully factored into the price. A low beta suggests it may not reach industry peer level soon. Financial health should also be considered.
Harmonic Inc's high P/S ratio is justified by anticipated robust future revenue. Confidence in this revenue sustains the share price, assuming accurate analyst predictions.
U.S. stock futures were trading within a tight range during Monday's evening deals after major benchmark averages posted moderate gains as investors look toward a fresh deluge of quarterly earnings results throughout the week. Yum China Holdings$ヤム チャイナ ホールディングス(YUMC.US)$fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected. Harmonic$ハーモニック(HLIT.US)$shed 13.7% after report...
Upgrades •$マルケタ(MQ.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $15 •$ノースウェスト ナチュラル(NWN.US)$: BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51) •$オーティス ワールドワイド(OTIS.US)$: Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80) •$スノーフレイク A(SNOW.US)$: Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325) Downgrades •$イートン(ETN.US)$: Barclays Downgrades to Underweight from Eq...
Gainers: •$ビーライト・バイオ(BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1) •$アトコア(ATKR.US)$+12.11% (earnings reports) •$AST スペースモバイル(ASTS.US)$+9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing) •$ハーモニック(HLIT.US)$+7.56% (earnings reports) •$ケマーズ(CC.US)$+7.2% ...
ハーモニックに関するコメント
Yum China Holdings $ヤム チャイナ ホールディングス(YUMC.US)$ fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected.
Harmonic $ハーモニック(HLIT.US)$ shed 13.7% after report...
• $マルケタ(MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $ノースウェスト ナチュラル(NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $オーティス ワールドワイド(OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $スノーフレイク A(SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $イートン(ETN.US)$ : Barclays Downgrades to Underweight from Eq...
• $ビーライト・バイオ(BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $アトコア(ATKR.US)$ +12.11% (earnings reports)
• $AST スペースモバイル(ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $ハーモニック(HLIT.US)$ +7.56% (earnings reports)
• $ケマーズ(CC.US)$ +7.2% ...
• $バンク ファースト コープ(BFC.US)$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2オープン ペアレント ホールディングス A(ETWO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $ハーモニック(HLIT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $マーケットアクセス ホールディングス(MKTX.US)$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF エナジー A(PBF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $レンジ リソーシーズ(RRC.US)$ : Piper S...
まだコメントはありません